Terms: = Lung cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
64 results:
1. Targeting neddylation as a novel approach to lung cancer treatment (Review).
Tian Z; Li J; Ma R; Li T; Sun Z; Huang S
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37083098
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract] [Full Text] [Related]
3. MIR4435-2HG Is a Potential Pan-cancer Biomarker for Diagnosis and prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract] [Full Text] [Related]
4. IDO1 plays a tumor-promoting role via mdm2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma.
Sun C; Li M; Zhang L; Sun F; Chen H; Xu Y; Lan Y; Zhang L; Lu S; Zhu J; Huang J; Wang J; Hu Y; Feng Y; Zhang Y
Cell Death Dis; 2022 Jun; 13(6):572. PubMed ID: 35760783
[TBL] [Abstract] [Full Text] [Related]
5. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-mdm2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract] [Full Text] [Related]
6. PPDPF Promotes the Progression and acts as an Antiapoptotic Protein in Non-Small Cell lung cancer.
Yun M; Yingzi L; Jie G; Guanxin L; Zimei Z; Zhen C; Zhi L; Yingjie N; Lunquan S; Tao C; Yuezhen D; Chengzhi Z
Int J Biol Sci; 2022; 18(1):214-228. PubMed ID: 34975328
[TBL] [Abstract] [Full Text] [Related]
7. Long Non-Coding RNA CRYBG3 Promotes lung cancer Metastasis via Activating the eEF1A1/mdm2/MTBP Axis.
Wu A; Tang J; Guo Z; Dai Y; Nie J; Hu W; Liu N; Ye C; Li S; Pei H; Zhou G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809929
[TBL] [Abstract] [Full Text] [Related]
8. Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell lung cancer.
Wang Z; Wan J; Liu C; Li L; Dong X; Geng H
Cancer Control; 2020; 27(1):1073274820956619. PubMed ID: 32951452
[TBL] [Abstract] [Full Text] [Related]
9. [Pulmonary artery intimal sarcoma: a clinicopathological analysis of three cases].
Li MN; Bao ML; Gong QX; Zhu Y; Li X; Song GX; Li HX; Fan QH
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):816-820. PubMed ID: 32746549
[No Abstract] [Full Text] [Related]
10. Primary resistance to first-generation EGFR-TKIs induced by mdm2 amplification in NSCLC.
Sun D; Zhu Y; Zhu J; Tao J; Wei X; Wo Y; Hou H
Mol Med; 2020 Jul; 26(1):66. PubMed ID: 32611363
[TBL] [Abstract] [Full Text] [Related]
11. Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct prognosis.
Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
[TBL] [Abstract] [Full Text] [Related]
12. [Intimal sarcoma of pulmonary arteries].
Sejben A; Tiszlavicz L; Furák J; Boros K; Sápi Z; Zombori T
Orv Hetil; 2020 Feb; 161(6):232-236. PubMed ID: 32008347
[TBL] [Abstract] [Full Text] [Related]
13. Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
Chen Y; Li H; Zhang W; Qi W; Lu C; Huang H; Yang Z; Liu B; Zhang L
Toxicol Appl Pharmacol; 2020 Jan; 387():114848. PubMed ID: 31809756
[TBL] [Abstract] [Full Text] [Related]
14. Association of mdm2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the mdm2-p53-Signaling Axis.
Singh A; Bhattacharyya N; Srivastava A; Pruett N; Ripley RT; Schrump DS; Hoang CD
Mol Ther; 2019 Sep; 27(9):1665-1680. PubMed ID: 31227395
[TBL] [Abstract] [Full Text] [Related]
16. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract] [Full Text] [Related]
17. SCF
Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
[TBL] [Abstract] [Full Text] [Related]
18. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
Castiglione R; Alidousty C; Holz B; Wagener S; Baar T; Heydt C; Binot E; Zupp S; Kron A; Wolf J; Merkelbach-Bruse S; Reinhardt HC; Buettner R; Schultheis AM
Mod Pathol; 2019 May; 32(5):627-638. PubMed ID: 30459450
[TBL] [Abstract] [Full Text] [Related]
20. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through mdm2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract] [Full Text] [Related]
[Next]
